Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant Ghanaian women

American Journal of Tropical Medicine and Hygiene

Volumn 65, Issue 1, 2001, Pages 21-26

  Mockenhaupt, F P ^a   Eggelte, T A ^a   Bohme T ^a   Thompson, W N A ^a   Bienzle, U ^a  

^a Institut fur Tropenmedizin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; ASPARAGINE; DIHYDROFOLATE REDUCTASE; FANSIDAR; ISOLEUCINE; PYRIMETHAMINE; THREONINE;

ALLELISM; ANEMIA; ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; GENE MUTATION; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALARIA; PLASMODIUM FALCIPARUM; PREGNANCY;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034897795     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2001.65.21     Document Type: Article

References (41)

1. An analysis of malaria in pregnancy in Africa
2. Malaria infection during pregnancy: Intrauterine growth retardation and preterm delivery in Malawi
3. The impact of placental malaria on gestational age and birth weight
4. Increase of birth weight following chloroquine chemoprophylaxis during the first pregnancy: Results of a randomized trial in Cameroon
5. Lack of efficacy of pyrimethamine prophylaxis in pregnant Nigerian women
6. Epidemiology of chloroquine-associated pruritus in Saradidi, Kenya
7. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: A randomised placebo-controlled trial
8. The epidemiology of drug-resistant malaria
9. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum
10. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria
11. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria
12. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance
13. Submicroscopic Plasmodium falciparum infections in pregnancy in Ghana
14. Malario-metric update for the rainforest and savanna of Ashanti region, Ghana
15. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction
16. Simple Dipstick Tests for the Determination of Antimalarials in Body Fluids
17. Sensitive ELISA dipstick test for the detection of chloroquine in urine under field conditions
18. Plasmodium falciparum: Detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion
19. Impact of chloroquine resistance on malaria mortality
20. Validity of mother's history regarding antimalarial drug use in Malawian children under five years old
21. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria
22. Plasmodium falciparum: Susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren
23. Molecular basis of in vivo resistance to sulfadoxine-pyrimethamine in African adult patients infected with Plasmodium falciparum malaria parasites
24. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania
25. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance
26. Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania
27. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali
28. Towards an understanding of the mechanism of pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: Genotyping of dihydrofolate reductase and dihydropteroate synthase of Kenyan parasites
29. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: A model for deterring resistance
30. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance
31. Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting
32. Population dynamics of Plasmodium falciparum in an unstable malaria area of eastern Sudan
33. Short report: High prevalence and imbalanced age distribution of the Plasmodium falciparum dihydrofolate reductase gene Asn-108 mutation in an area of low pyrimethamine usage in Nigeria
34. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta
35. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria
36. Plasmodium falciparum isolates from infected pregnant women and children are associated with distinct adhesive and antigenic properties
37. Maternal antibodies block malaria
38. Evaluation of maternal practices, efficacy, and cost-effectiveness of alternative antimalarial regimens for use in pregnancy: Chloroquine and sulfadoxine-pyrimethamine
39. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil